Colorectal cancer: Screening and surveillance for high-risk individuals

Expert Review of Anticancer Therapy

Volumn 3, Issue 6, 2003, Pages 851-862

  Ferrández, Angel ^a   DiSario, James A ^b  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

Colon cancer; Colonoscopy; Family history; Personal history; Screening syndromic colon cancer

Indexed keywords

ADENOMATOUS POLYP; AGE DISTRIBUTION; ANAMNESIS; BARIUM ENEMA; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CARCINOGENESIS; COLON CANCER; COLON POLYP; COLONOSCOPY; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; COWDEN SYNDROME; FAMILIAL CANCER; FAMILY HISTORY; FECES ANALYSIS; GENETIC SCREENING; HIGH RISK PATIENT; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PEUTZ JEGHERS SYNDROME; REVIEW; RISK FACTOR; SIGMOID;

EID: 0346958294     PISSN: 14737140     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737140.3.6.851     Document Type: Review

References (66)

1. Burt RW. Colon cancer screening. Gastroenterology 119, 837-853 (2000).
2. Lichtenstein P, Holm NV, Verkasalo PK et al. Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark and Finland. N. Engl. J. Med. 343(2), 78-85 (2000).
3. Chung DC. The genetic basis of CRC: insights into critical pathways of tumorigenesis. Gastroenterology 119(3), 854-865 (2000).
4. Pardi DS, Loftus EV Jr, Kremers WK, Keach J, Lindor KD. Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology 124(4), 889-893 (2003).
5. Pignone M, Saha S, Hoerger T, Mandelblatt J. Cost-effectiveness analysis of colorectal cancer screening: a systematic review for the US Preventive Services Task Force. Ann. Intern. Med. 137(2), 96-104 (2002).
6. Helm JF, Russo MW, Biddle AK, Simpson KN, Ransohoff DF, Sandler RS. Effectiveness and economic impact of screening for CRC by mass fecal occult blood testing. Am. J. Gastroenterol. 95(11), 3250-3258 (2000).
7. Ransohoff DF, Lang CA. Screening for CRC with fecal occult blood test: a background paper. Ann. Intern. Med. 126, 811-822 (1997).
8. Church TR, Ederer F, Mandel JS. Fecal occult blood screening in the Minnesota study: sensitivity of the screening test. J. Natl Cancer Inst. 89, 1440-1448 (1997).
9. Hardcastle JD, Chamberalin JO, Robinson MHE et al. Randomized controlled trial of fecal occult blood screening for CRC. Lancet 348, 1472-1477 (1996).
10. Kronborg O, Fenger C, Olsen J et al. Randomized study of screening for CRC with fecal occult blood test. Lancet 348(9040), 1467-1471 (1996).
11. Mandel JS, Church TR, Bond JH et al. The effect of fecal occult-blood screening on the incidence of CRC. N. Engl. J. Med. 343(22), 1603-1607 (2000).
12. Pignone M, Campbell MK, Carr C, Phillips C. Meta-analysis of dietary restriction during fecal occult blood testing. Eff. Clin. Pract. 4(4), 150-156 (2001).
13. Mandel JS, Bond JH, Church TR et al. Reducing mortality from CRC by screening for fecal occult blood. N. Engl. J. Med. 328, 1365-1371 (1993).
14. Winawer S, Fletcher R, Rex D et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale - update based on new evidence. Gastroenterology 124(2), 544-560 (2003).
15. Mandel JS, Church TR, Ederer F, Bond JH. CRC mortality: effectiveness of biennial screening for fecal occult blood. J. Natl Cancer Inst. 91, 434-437 (1999).
16. Gatto NM, Frucht H, Sundararajan V, Jacobson JS, Grann VR, Neugut AI. Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study. J. Natl Cancer Inst. 95(3), 230-236 (2003).
17. UK Flexible Sigmoidoscopy Screening Trial Investigators and Atkin WS. Single flexible sigmoidoscopy screening to prevent CRC: baseline findings of a UK multicentre randomised trial. Lancet 359(9314), 1291-1300 (2002).
18. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening, sigmoidoscopy and CRC mortality. J. Natl Cancer Inst. 84(20), 1572-1575 (1992).
19. Zubarik R. Ganguly E, Benway D, Ferrentino N, Moses P, Vecchio J. Procedure-related abdominal discomfort in patients undergoing colorectal cancer screening: a comparison of colonoscopy and flexible sigmoidoscopy. Am. J. Gastroenterol. 97(12), 3056-3061 (2002).
20. Selby J, Friedman GD, Quesenberry CP, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from CRC. N. Engl. J. Med. 326(10), 653-657 (1992).
21. Muller AD, Sonnenberg A. Prevention of CRC by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans. Ann. Int. Med. 123, 904-910 (1995).
22. Winawer SJ, Flehinger BH, Schottenfeld D, Miller DG. Screening for CRC with fecal occult blood testing and sigmoidoscopy. J. Natl Cancer Inst. 85(16), 1311-1318 (1993).
23. Lieberman DA, Weiss DG. One time screening for CRC with combined fecal occult-blood testing and examination of the distal colon. N. Engl. J. Med. 345, 555-560 (2001).
24. Rex DK, Rahmani EY, Haseman JH, Lemmel GT, Kaster S, Buckley JS. Relative sensitivity of colonoscopy and barium enema for detection of CRC in clinical practice. Gastroenterology 112(1), 117-123 (1997).
25. Winawer SJ, Stewart ET, Zauber AG et al. A comparison of colonoscopy and double contrast barium enema for surveillance after polypectomy. N. Engl. J. Med. 324(24), 1766-1772 (2000).
26. Scheitel SM, Ahlquist DA, Wollan PC, Hagen PT, Silverstein MD. Colorectal cancer screening: a community case-control study of proctosigmoidoscopy, barium enema radiography and fecal occult blood test efficacy. Mayo Clin. Proc. 74(12), 1207-1213 (1999).
27. Rex DK, Johnson DA, Lieberman DA, Burt RW, Sonnenberg A. CRC prevention 2000: screening recommendations of the American College of Gastroenterology. Am. J. Gastroenterol. 95(4), 868-877 (2000).
28. Winawer SJ, Zauber AG, Ho MN et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N. Engl. J. Med. 329(27), 2028-2029 (2003).
29. DiSario JA, Foutch PG, Mai HD, Pardy K, Manne RK. Prevalence and malignant potential of colorectal polyps in asymptomatic, average-risk men. Am. J. Gastroenterol. 86(8), 941-945 (1991).
30. Lieberman DA, Weiss DG, Bond J, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for CRC. N. Engl. J. Med. 343(3), 162-169 (2000).
31. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal finding. N. Engl. J. Med. 343, 169-174 (2000).
32. Vijan S, Hwang EW, Hofer TP, Hayward RA. Which colon cancer screening test? A comparison of costs, effectiveness and compliance. Am. J. Med. 111(8), 593-601 (2001).
33. Giardiello FM, Brensinger JD, Petersen GM et al. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N. Engl. J. Med. 336(12), 823-827 (1997).
34. Ramsey SD, Clarke L, Etzioni R, Higashi M, Berry K, Urban N. Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis CRC. Ann. Intern. Med. 135(8 Pt 1), 577-588 (2001).
35. Smith RA, von Eschenbach AC, Wender R et al. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal and endometrial cancers. Also: update 2001 - testing for early lung cancer detection. CA Cancer J. Clin. 51(1), 38-75 (2001).
36. Johns LE, Houlston RS. A systematic review and meta-analysis of familial CRC risk. Am. J. Gastroenterol. 96(10), 2992-3003 (2001).
37. St John DJ, McDermott FT, Hopper JL, Debney EA, Johnson WR, Hughes ES. Cancer risk in relatives of patients with common colorectal cancer. Ann. Intern. Med. 118(10), 785-790 (1993).
38. Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Speizer FE, Willett WC. A prospective study of family history and the risk of colorectal cancer. N. Engl. J. Med. 331(25), 1669-1674 (1994).
39. Niv Y, Dickman R, Figer A, Abuksis G, Fraser G. Case-control study of screening colonoscopy in relatives of patients with colorectal cancer. Am. J. Gastroenterol. 98, 486-489 (2003).
40. Ahsan H, Neugut AI, Garbowski GC et al. Family history of colorectal adenomatous polyps and increased risk for colorectal cancer. Ann. Intern. Med. 128, 900-905 (1998).
41. Winawer SJ, Zauber AG, Gerdes H et al. and the National Polyp Study Workgroup. Risk of colorectal cancer in the families of patients with adenomatous polyps. N. Engl. J. Med. 334, 82-87 (1996).
42. Lynch L, Ahnen DJ, Byers T, Weiss DG, Lieberman DA and the Veterans Affairs Co-operative Study Group no. 380. First-degree relatives of patients with advanced colorectal adenomas have an increased prevalence of colorectal cancer. Clin. Gastroenterol. Hepatol. 1, 96-102 (2003).
43. Thiis-Evensen E, Hoff GS, Sauar J, Langmark F, Majak BM, Vatn MH. Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scand. J. Gastroenterol. 34(4), 414-420 (1999)
44. Winawer SJ, Zauber AG, O'Brien MJ et al. and the National Polyp Study Workgroup. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. N. Engl. J. Med. 328, 901-906 (1993).
45. Citarda F, Tomaselli G, Capocaccia R, Barcherini S, Crespi M and the Italian Multicentre Study Group. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut 48(6), 812-815 (2001).
46. Cali RL, Pitsch RM, Thorson AG et al. Cumulative incidence of metachronous colorectal cancer. Dis. Colon Rectum 6, 388-393 (1993).
47. Jahn H, Joergensen OD, Kronborg O, Fenger C. Can Hemoccult-II replace colonoscopy in surveillance after radical surgery for colorectal cancer and after polypectomy? Dis. Colon Rectum 35, 253-256 (1992).
48. Scholefield JH, Steele RJ. Guidelines for follow-up after resection of colorectal cancer. Gut 51 (Suppl. 5), V3-V5 (2002).
49. Green RJ, Metlay JP, Propert K et al. Surveillance for second primary colorectal cancer after adjuvant chemotherapy: an analysis of Intergroup 0089. Ann. Intern. Med. 136, 261-269 (2002).
50. Schoemaker D, Black R, Giles L, Toouli J. Yearly colonoscopy, liver CT and chest radiography do not influence 5-year survival of colorectal cancer patients. Gastroenterology 114, 7-14 (1998).
51. Meyerhardt JA, Mayer RJ. Follow-up strategies after curative resection of colorectal cancer. Semin. Oncol. 30(3), 349-360 (2003).
52. Berman JM, Cheung RJ, Weinberg DS. Surveillance after colorectal cancer resection. Lancet 355(9201), 395-399 (2000).
53. Burt RW. Polyposis syndromes. In: Textbook of Gastroenterology, 4th edition. Yamada T, Alpers DH, Laine L, Kaplowitz N, Owyang C, Powell DW (Eds), Lippincott Williams & Wilkins, MD, USA (2003).
54. Vasen HFA, Watson P, Mecklin JP and the ICG-HNPCC. New clinical criteria for hereditary nonpolyposis CRC (HNPCC, Lynch Syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 116, 1453-1456 (1999).
55. Chung DC, Rustgi AK. The hereditary nonpolyposis colorectal cancer syndrome: genetics and clinical implications. Ann. Intern. Med. 138(7), 560-570 (2003).
56. Traverso G, Shuber A, Levin B et al. Detection of APC mutations in fecal DNA from patients with colorectal tumors. N. Engl. J. Med. 346(5), 311-320 (2002).
57. Traverso G, Shuber A, Olsson L et al. Detection of proximal CRCs through analysis of faecal DNA. Lancet 359, 403-404 (2002).
58. Ahlquist DA, Skoletsky JE, Boynton KA et al. CRC screening by detection of altered human DNA in stool: feasibility of a multi-target assay system. Gastroenterology 119, 1219-1227 (2000).
59. Levin B, Brooks D, Smith RA, Stone A. Emerging technologies in screening for colorectal cancer: CT colonography, immunochemical fecal occult blood tests and stool screening using molecular markers. CA Cancer J. Clin. 53(1), 44-55 (2003).
60. Edwards JT, Wood CJ, Mendelson RM, Forbes GM. Extracolonic findings at virtual colonoscopy: implications for screening programs. Am. J. Gastroenterol. 96, 3009-3012 (2001).
61. Fenlon HM, Nunes DP, Schroy PC III, Barish MA, Clarke PD, Ferrucci JT. A comparison of virtual and conventional colonoscopy for the detection of colorectal polyps. N. Engl. J. Med. 341(20), 1496-1503 (1999).
62. Yee J, Akerkar GA, Hung RK, Steinauer-Gebauer AM, Wall SD, McQuaid KR. Colorectal neoplasia: performance characteristics of CT colography for detection in 300 patients. Radiology 219, 685-692 (2001).
63. Kay CL, Kulling D, Hawes RH, Young JW, Cotton PB. Virtual endoscopy: comparison with colonoscopy in the detection of space occupying lesions within the colon. Endoscopy 32(3), 226-232 (2000).
64. Johnson CD, Harmsen WS, Wilson LA et al. Prospective blinded evaluation of computed tomographic colonography for screen detection of colorectal polyps. Gastroenterology 125(2), 311-319 (2003).
65. Lauenstein TC, Goehde SC, Debatin JF. Fecal tagging: MR colonography without colonic cleansing. Abdom. Imaging 27(4), 410-417 (2002).
66. Appleyard M, Fireman Z, Glukhovsky A et al. A randomized trial comparing wireless capsule endoscopy with push enteroscopy for the detection of small-bowel lesions. Gastroenterology 119(6), 1431-1438 (2000).